Chester County News and Community Website
WEST BRANDYWINE, PA — In an inspiring show of community spirit and commitment, Freedom Village at Brandywine marked World Parkinson’s Day by joining the “Pump it for Parkinson’s” initiative led …
Freedom Village Steps Up for Parkinson’s Awareness with Record-Breaking Initiative Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) has recently announced the completion of the last patient visit in its phase III study of buntanetap, a leading candidate for treating …
Annovis Bio Finalizes Phase III Study of Buntanetap in Early Parkinson’s Treatment, Awaits Topline Data Read More BERWYN, PA — In a recent breakthrough, Annovis Bio (NYSE: ANVS), a biopharmaceutical company, has successfully performed measurements of critical biomarkers in the plasma of Parkinson’s disease patients. Utilizing buntanetap, …
Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease Read More
PAOLI, PA — According to the Parkinson’s Foundation, nearly 1 million people in the United States are living with Parkinson’s Disease (PD), and that number is expected to rise to …
SageLife Delivering Results for Individuals with Parkinson’s and Movement Disorders Read More BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced that the Company will hold a live R&D webcast on Thursday, April 20th at 4 pm EDT to review its clinical development programs in Alzheimer’s disease …
Annovis Bio to Hold Live Webcast to Review Alzheimer’s Disease and Parkinson’s Disease Clinical Programs Read More BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced recent approval for additional European clinical trial sites for the ongoing Phase 3 study of buntanetap for the treatment of Parkinson’s disease (“PD”).
Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap Read More